Literature DB >> 27789106

Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.

Saman Rezazadeh1, Jiqing Guo1, Henry J Duff1, Raechel A Ferrier2, Brenda Gerull3.   

Abstract

Andersen-Tawil syndrome (ATS) is caused by mutations in KCNJ2 (Kir2.1). It remains unclear whether dilated cardiomyopathy (DCM) is a primary feature of ATS. We studied a proband with typical physical features of ATS plus DCM and moderate to severe left ventricular dysfunction (left ventricular ejection fraction = 30.5%). Genetic screening revealed a novel mutation in Kir2.1 (c.665T>C, p.L222S). Functional studies showed that this mutation reduced ionic currents in a dominant-negative manner. Suppression of ventricular arrhythmias with bisoprolol led to normalization of left ventricular size and function. We conclude that DCM is likely a secondary phenotype in ATS and is caused by high ventricular arrhythmia burden. Copyright Â
© 2016 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27789106     DOI: 10.1016/j.cjca.2016.07.587

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  3 in total

Review 1.  Inward rectifier potassium (Kir) channels in the retina: living our vision.

Authors:  Katie M Beverley; Bikash R Pattnaik
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

Review 2.  Extraoral Taste Receptor Discovery: New Light on Ayurvedic Pharmacology.

Authors:  Marilena Gilca; Dorin Dragos
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-31       Impact factor: 2.629

Review 3.  Clinical Genetics of Inherited Arrhythmogenic Disease in the Pediatric Population.

Authors:  Estefanía Martínez-Barrios; Sergi Cesar; José Cruzalegui; Clara Hernandez; Elena Arbelo; Victoria Fiol; Josep Brugada; Ramon Brugada; Oscar Campuzano; Georgia Sarquella-Brugada
Journal:  Biomedicines       Date:  2022-01-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.